Training and Support for Hybrid Closed-Loop Therapy.
Journal of diabetes science and technology
Diabetes Technology Society
MetadataShow full item record
Boughton, C., Hartnell, S., Allen, J. M., Fuchs, J., & Hovorka, R. (2020). Training and Support for Hybrid Closed-Loop Therapy.. Journal of diabetes science and technology, 1932296820955168. https://doi.org/10.1177/1932296820955168
Hybrid closed-loop therapy is an emerging technology transforming management of type 1 diabetes. Research studies demonstrate glycaemic and quality of life benefits of hybrid closed-loop therapy for people with T1D. Translating these outcomes into standard clinical practice is critical for reimbursement and improving access to this technology. High quality training is essential for achieving optimal outcomes with hybrid closed-loop therapy. Basic diabetes skills and tasks are as important, or even more important, with closed-loop therapy than with standard insulin therapy and need to be reiterated. Establishing expectations of hybrid closed-loop therapy clearly at the outset promotes long-term usage and optimal outcomes. We share key aspects of training and support for users of commercially available hybrid closed-loop systems and consider who may benefit from this technology.
Department of Health (via National Institute for Health Research (NIHR)) (EME 14/23/09)
Wellcome Trust (100574/B/12/Z)
Helmsley Charitable Trust (#2016PG-T1D046)
Cambridge University Hospitals NHS Foundation Trust (CUH) (146281)
External DOI: https://doi.org/10.1177/1932296820955168
This record's URL: https://www.repository.cam.ac.uk/handle/1810/309345
All rights reserved